Cervical Cancer

Pathologists and laboratory professionals are key members of the multidisciplinary cancer care team, with roles in the diagnosis, testing, and management of diseases such as cervical cancer. ASCP is dedicated to keeping you abreast of cervical cancer screening strategy and guidelines to improve patient care.

Cervical Cancer Screening in 2022: Why Co-Testing is Essential for Patient-Centered Care

Roundtable Discussion

On February 22, 2022, ASCP CEO Blair Holladay, PhD, MASCP, SCT(ASCP)^CM, moderated a roundtable discussion on cervical cancer screening strategy in the U.S. Dr. Holladay and a multi-disciplinary panel of experts featuring cytopathologists and Ob/Gyns used patient case-based reviews to address the following topics:

Proven benefits of co-testing (Pap + hrHPV) for detection of precancers and cancers
Impact of new screening guidelines on women’s health and patient care
Strategies for further reducing cervical cancer in populations who experience healthcare inequities
Role of healthcare professionals, pathology and laboratory medicine in patient support and education

Featured Panelists

Adrienne Stevenson, MD, OBGYN

Darren Wheeler, MD, FASCP, Pathologist and Regional Anatomic Pathology Medical Director, West & South East, Quest Diagnostics & AmeriPath, Inc.

Amita Murthy, MD, MPH, OBGYN at NYC Department of Health

Diane D. Davey, MD, Associate Dean, Graduate Medical Education, Professor of Pathology at the University of Central Florida

Roundtable Discussion

Cervical Cancer Screening in 2022: Why Co-Testing is Essential for Patient-Centered Care

Watch on YouTube

First Name *
Last Name *
Email *
Customer ID

Name *
Country Code *
Phone Number *
Scheduled Date *
Scheduled Time *
Customer Id